We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 101-120 of 10,000 results
  1. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature

    Secondary sclerosing cholangitis in critically ill patients (SC-CIP) is a rare disease characterized by chronic cholestasis. The underlying...

    Ulrike Bauer, Desislava Pavlova, ... Ursula Ehmer in Clinical Journal of Gastroenterology
    Article Open access 11 August 2022
  2. How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?

    In patients with primary sclerosing cholangitis (PSC), antimicrobial therapy with oral vancomycin (OV) is increasingly used to prevent progression of...

    Ayesha Shah, Sahar Pakneeshan, ... Gerald Holtmann in Indian Journal of Gastroenterology
    Article Open access 10 October 2022
  3. Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis

    Background

    Despite emerging reports of secondary sclerosing cholangitis (SSC) in critically ill COVID-19 patients little is known about its imaging...

    Soleen Ghafoor, Manon Germann, ... Daniel Stocker in Insights into Imaging
    Article Open access 08 August 2022
  4. A comparison of the vancomycin calcium sulfate implantation versus fenestration decompression for the treatment of sclerosing osteomyelitis

    Objective

    To compare the clinical efficacy of vancomycin calcium sulfate implantation and fenestration decompression in the treatment of sclerosing...

    Haotian Hua, **nwei Wang, ... Jiangfei Chen in BMC Musculoskeletal Disorders
    Article Open access 29 November 2021
  5. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis

    Primary sclerosing cholangitis (PSC) is characterized by progressive biliary inflammation and fibrosis. Although gut commensals are associated with...

    Masataka Ichikawa, Nobuhiro Nakamoto, ... Takanori Kanai in Nature Communications
    Article Open access 05 June 2023
  6. Ovarian Sclerosing Stromal Tumor

    Ovarian sclerosing stromal tumor is a benign neoplasm classified among the pure stromal tumors (along with ovarian fibroma, thecoma, Leydig cell...
    Simone Mocellin in Soft Tissue Tumors
    Chapter 2021
  7. PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis

    Background

    Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease leading to biliary fibrosis and cirrhosis. Cilofexor is a...

    Michael Trauner, Chuhan Chung, ... Robert P. Myers in BMC Gastroenterology
    Article Open access 15 March 2023
  8. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study

    Background and aims

    Little is known regarding the epidemiology and outcomes of patients with primary sclerosing cholangitis (PSC) in Australia. We,...

    Natassia Tan, N. Ngu, ... A. Majeed in Hepatology International
    Article Open access 03 June 2022
  9. Sclerosing Perineurioma: a Rare Cause of Thumb Mass

    Augustine Chavez, Shelley Noland, Ana Aragon Sierra in Journal of General Internal Medicine
    Article 06 July 2022
  10. Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

    Background

    It remains unclear whether ursodeoxycholic acid (UDCA) treatment improves long-term outcomes in patients with primary sclerosing...

    Toshihiko Arizumi, Susumu Tazuma, ... Atsushi Tanaka in Journal of Gastroenterology
    Article 06 September 2022
  11. Case 2: Nodular Sclerosing Hodgkin’s Lymphoma

    There is a bulky nodular sclerosing Hodgkin’s lymphoma with F-18 PET for treatment assessment.
    Ching Yee Oliver Wong, Dafang Wu in Phenotypic Oncology PET
    Chapter 2022
  12. Primary Sclerosing Cholangitis

    Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive biliary inflammation and fibrosis. PSC has a...
    Laura Cristoferi, Alessio Gerussi, ... Pietro Invernizzi in Diseases of the Liver and Biliary Tree
    Chapter 2021
  13. Patient-Predicted Outcomes Are Associated with Quality of Life in Patients with Primary Sclerosing Cholangitis

    Background

    Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease, and many patients ultimately require liver transplantation...

    Jacqueline B. Henson, James H. Helzberg, Andrew J. Muir in Digestive Diseases and Sciences
    Article 28 March 2022
  14. A case of immunoglobulin G4-related sclerosing mesenteritis without other organ involvement

    A 64-year-old man presented to our hospital with abdominal pain and 4–5 episodes of watery diarrhea per day for 2 months. Abdominal ultrasound...

    Masaya Kozono, Shiroh Tanoue, ... Akio Ido in Clinical Journal of Gastroenterology
    Article 07 June 2021
  15. Endoscopic Management of Primary Sclerosing Cholangitis

    PSC is a chronic progressive disease of the bile ducts that can lead to symptoms related to cholestasis, liver failure, and hepatobiliary malignancy....
    Reference work entry 2022
  16. MR elastography in primary sclerosing cholangitis: a pictorial review

    Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary ductal inflammation and fibrosis causing both...

    Christopher L. Welle, Patrick J. Navin, ... Sudhakar K. Venkatesh in Abdominal Radiology
    Article 14 May 2022
  17. The disturbance of the distribution of T helper cell subsets in the mantle area surrounding germinal centers in immunoglobulin G4–related sclerosing sialadenitis

    The function of germinal centers (GCs) is an important factor in the pathogenesis of immunoglobulin G4 (IgG4)–related disease, in which inflammatory...

    Satomi Kasashima, Atsuhiro Kawashima, ... Kenichi Harada in Virchows Archiv
    Article 28 July 2022
  18. Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas

    Purpose of the review

    Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and frequently fatal neurodegenerative disorder caused...

    Pauline Samia, Katherine Oyieke, ... Banu Anlar in Current Treatment Options in Neurology
    Article Open access 19 March 2022
Did you find what you were looking for? Share feedback.